Axikin Garners $3 Million Venture Capital Funding
Friday, January 23, 2009 5:38:00 AM PDT | VentureDeal Staff
San Diego, California -- Stealth mode of pharmaceutical company Axikin Pharmaceuticals (no website) has secured $3 million in its series A round of venture capital investment.
Axikin is a very early stage pharmaceutical company that is developing as-yet unspecified drugs and treatments.
Sanderling Ventures was the lead investor in the round, which also included Mitsui & Co. Venture Partners. Proceeds purposes from the financing were not disclosed.
Email Page | Print Page